Literature DB >> 22878591

Advanced gestational age increases serum carbohydrate-deficient transferrin levels in abstinent pregnant women.

Ludmila N Bakhireva1, Sandra Cano, William F Rayburn, Renate D Savich, Lawrence Leeman, Raymond F Anton, Daniel D Savage.   

Abstract

AIMS: Carbohydrate-deficient transferrin (%CDT) is a well-established and highly specific biomarker for sustained heavy consumption of alcohol. However, in pregnant women, the specificity of this biomarker might be affected by advanced gestational age, even after accounting for increased transferrin concentrations in pregnancy. The goal of this prospective study was to assess the variability in %CDT during pregnancy among alcohol-abstaining patients.
METHODS: Patients were recruited during one of the first prenatal care visits and followed-up to term. Abstinence was confirmed by maternal self-report and by alcohol biomarkers. Biomarkers assessed in the mother included serum gamma-glutamyltranspeptidase, urine ethyl glucuronide and ethyl sulfate, and whole blood phosphatidylethanol (PEth). In addition, PEth was measured in a dry blood spot card obtained from a newborn. For %CDT analysis, serum samples were collected at baseline and at term and analyzed by an internationally validated high-performance liquid chromatography and spectrophotometric detection method.
RESULTS: At recruitment (mean gestational age 22.6 ± 7.3 weeks), the mean %CDT concentration was 1.49 ± 0.30%, while at term, it increased to 1.67 ± 0.28% (P = 0.001). Using a conventional cutoff concentration %CDT >1.7%, 22.9 and 45.7% of the sample would be classified as 'positive' for this biomarker at recruitment and at term, respectively (P = 0.011 ).
CONCLUSION: These results suggest that a conventional cutoff of 1.7% might be too low for pregnant women and would generate false-positive results. We propose that %CDT >2.0% be used as a cutoff concentration indicative of alcohol exposure in pregnant women. The sensitivity of %CDT at this cutoff for heavy drinking during pregnancy needs to be assessed further.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22878591      PMCID: PMC3472616          DOI: 10.1093/alcalc/ags087

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  25 in total

Review 1.  Carbohydrate-deficient transferrin for detection and monitoring of sustained heavy drinking. What have we learned? Where do we go from here?

Authors:  R F Anton
Journal:  Alcohol       Date:  2001-11       Impact factor: 2.405

2.  Measurement and interpretation of drinking behavior. I. On measuring patterns of alcohol consumption. II. Relationships between drinking behavior and social adjustment in a sample of problem drinkers.

Authors:  R S Bowman; L I Stein; J R Newton
Journal:  J Stud Alcohol       Date:  1975-09

3.  Detecting risk drinking during pregnancy: a comparison of four screening questionnaires.

Authors:  M Russell; S S Martier; R J Sokol; P Mudar; S Jacobson; J Jacobson
Journal:  Am J Public Health       Date:  1996-10       Impact factor: 9.308

4.  The T-ACE questions: practical prenatal detection of risk-drinking.

Authors:  R J Sokol; S S Martier; J W Ager
Journal:  Am J Obstet Gynecol       Date:  1989-04       Impact factor: 8.661

5.  Validity of maternal report of prenatal alcohol, cocaine, and smoking in relation to neurobehavioral outcome.

Authors:  Sandra W Jacobson; Lisa M Chiodo; Robert J Sokol; Joseph L Jacobson
Journal:  Pediatrics       Date:  2002-05       Impact factor: 7.124

Review 6.  Carbohydrate-deficient transferrin as a marker of chronic alcohol abuse: a critical review of preanalysis, analysis, and interpretation.

Authors:  T Arndt
Journal:  Clin Chem       Date:  2001-01       Impact factor: 8.327

7.  American Academy of Pediatrics. Committee on Substance Abuse and Committee on Children With Disabilities. Fetal alcohol syndrome and alcohol-related neurodevelopmental disorders.

Authors: 
Journal:  Pediatrics       Date:  2000-08       Impact factor: 7.124

8.  Carbohydrate-deficient transferrin quantified by HPLC to determine heavy consumption of alcohol.

Authors:  J O Jeppsson; H Kristensson; C Fimiani
Journal:  Clin Chem       Date:  1993-10       Impact factor: 8.327

9.  Improved HPLC method for carbohydrate-deficient transferrin in serum.

Authors:  Anders Helander; Asgeir Husa; Jan-Olof Jeppsson
Journal:  Clin Chem       Date:  2003-11       Impact factor: 8.327

Review 10.  A review of genetic, biological, pharmacological, and clinical factors that affect carbohydrate-deficient transferrin levels.

Authors:  Michael F Fleming; Raymond F Anton; Claudia D Spies
Journal:  Alcohol Clin Exp Res       Date:  2004-09       Impact factor: 3.455

View more
  13 in total

1.  Validity of Self-Reported Drug Use Information Among Pregnant Women.

Authors:  Mahek Garg; Laura Garrison; Lawrence Leeman; Ajna Hamidovic; Matthew Borrego; William F Rayburn; Ludmila Bakhireva
Journal:  Matern Child Health J       Date:  2016-01

2.  The effect of prenatal alcohol co-exposure on neonatal abstinence syndrome in infants born to mothers in opioid maintenance treatment.

Authors:  Christine Kreitinger; Hilda Gutierrez; Ajna Hamidovic; Cheryl Schmitt; Preeyaporn Sarangarm; William F Rayburn; Lawrence Leeman; Ludmila N Bakhireva
Journal:  J Matern Fetal Neonatal Med       Date:  2015-03-23

3.  Hepatitis C Cascade of Care Among Pregnant Women on Opioid Agonist Pharmacotherapy Attending a Comprehensive Prenatal Program.

Authors:  Kimberly Page; Lawrence Leeman; Steven Bishop; Sandra Cano; Ludmila N Bakhireva
Journal:  Matern Child Health J       Date:  2017-09

4.  Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5-8 months of age.

Authors:  Ludmila N Bakhireva; Bradley D Holbrook; Shikhar Shrestha; Yuridia Leyva; Malia Ashley; Sandra Cano; Jean Lowe; Julia M Stephen; Lawrence Leeman
Journal:  Early Hum Dev       Date:  2018-12-13       Impact factor: 2.079

5.  The feasibility and cost of neonatal screening for prenatal alcohol exposure by measuring phosphatidylethanol in dried blood spots.

Authors:  Ludmila N Bakhireva; Renate D Savich; Dennis W Raisch; Sandra Cano; Robert D Annett; Lawrence Leeman; Mahek Garg; Chelsea Goff; Daniel D Savage
Journal:  Alcohol Clin Exp Res       Date:  2013-02-19       Impact factor: 3.455

6.  The validity of phosphatidylethanol in dried blood spots of newborns for the identification of prenatal alcohol exposure.

Authors:  Ludmila N Bakhireva; Lawrence Leeman; Renate D Savich; Sandra Cano; Hilda Gutierrez; Daniel D Savage; William F Rayburn
Journal:  Alcohol Clin Exp Res       Date:  2014-02-11       Impact factor: 3.455

7.  Fetal Growth Outcomes in a Cohort of Polydrug- and Opioid-Dependent Patients.

Authors:  Laura Garrison; Lawrence Leeman; Renate D Savich; Hilda Gutierrez; William F Rayburn; Ludmila N Bakhireva
Journal:  J Reprod Med       Date:  2016 Jul-Aug       Impact factor: 0.142

8.  Ethylglucuronide in maternal hair as a biomarker of prenatal alcohol exposure.

Authors:  Hilda L Gutierrez; Lauren Hund; Shikhar Shrestha; William F Rayburn; Lawrence Leeman; Daniel D Savage; Ludmila N Bakhireva
Journal:  Alcohol       Date:  2015-07-21       Impact factor: 2.405

9.  Diagnostic sensitivity of carbohydrate deficient transferrin in heavy drinkers.

Authors:  Kevin J Fagan; Katharine M Irvine; Brett C McWhinney; Linda M Fletcher; Leigh U Horsfall; Lambro Johnson; Peter O'Rourke; Jennifer Martin; Ian Scott; Carel J Pretorius; Jacobus P J Ungerer; Elizabeth E Powell
Journal:  BMC Gastroenterol       Date:  2014-05-22       Impact factor: 3.067

10.  Alcohol Use During Pregnancy is Associated with Specific Alterations in MicroRNA Levels in Maternal Serum.

Authors:  Amy S Gardiner; Hilda L Gutierrez; Li Luo; Suzy Davies; Daniel D Savage; Ludmila N Bakhireva; Nora I Perrone-Bizzozero
Journal:  Alcohol Clin Exp Res       Date:  2016-04       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.